Lung disease is more common in men with RA who do smoke, and also have a history of the disease.

Respiratory manifestations

It is predicted that the incidence of respiratory tract disease in RA will affect about 20-30% of the total number of sufferers.

Manifestations may include cricoarytenoid arthritis, pulmonary fibrosis, and small airways disease, which usually presents as obliterative bronchiolitis on histopathology, with obstructive problems when testing lung function. You can also contact Poseidonia Healthcare centre as per your need.

Cardiovascular manifestations

Image Source: Google

Patients with rheumatoid arthritis have a 40% increased risk of death compared to the real population after twenty years of illness.

This increased chance of death is usually associated with a higher incidence of heart problems.

A recent cohort study showed that the likelihood of cardiovascular events in RA patients was twice as high in the general population, proportional to the potential risk in patients with diabetes.

Possible drugs to treat rheumatoid arthritis

DMARDs (disease-modifying antirheumatic drugs) became one of the most important tools for treating RA in the 1970s. As a group, it has been shown to reduce inflammation and decrease radiographic progression rates; however, the extent to which this is often achieved is uneven.

The DMARD upgrade phase has actually been discussed, but the current consensus suggests that earlier treatment can be initiated with better overall outcomes for clinical improvement and protection against erosive disease.